Place of methyl phenidate hydrochloride in psychiatric practice.
D003863:Depression / Q000628:therapy*; D003866:Depressive Disorder; D008774:Methylphenidate / Q000627:therapeutic use*; D012110:Reserpine / Q000009:adverse effects*; D012492:Salts
D012492:Salts; D008774:Methylphenidate; D012110:Reserpine
DEPRESSION/therapy; METHYLPHENIDYLACETATE/therapeutic use; RESERPINE/injurious effects
Klin Wochenschr. 1954 May 15;32(19-20):445-50
13164273
Dis Nerv Syst. 1956 Oct;17(10):317-21
13365514
Antibiotic Med Clin Ther (New York). 1956 Oct;3(5):309-11
13363370
J Am Geriatr Soc. 1957 Apr;5(4):421-9
13428528
N Y State J Med. 1957 May 15;57(10):1753-7
13430932
Med Ann Dist Columbia. 1956 Sep;25(9):491-4; passim
13358300
J Ment Sci. 1957 Oct;103(433):830-4
13481594
Medizinische. 1956 Feb 18;(7):260-2
13308698
Med Monatsschr. 1954 May;8(5):306-10
13193449
Minerva Anestesiol. 1955 Jun;21(6):125-8
13244387
Ann N Y Acad Sci. 1955 Apr 15;61(1):101-7
14377277
Lancet. 1956 Mar 24;270(6917):338
13307923
Medizinische. 1955 Apr 16;16:606-8
14383108
Proc Staff Meet Mayo Clin. 1956 Nov 14;31(23):620-5
13379528
Med Klin (Munich). 1955 May 20;50(20):864-6
14393410
Am J Psychiatry. 1956 Dec;113(6):546-7
13372823
Schweiz Med Wochenschr. 1956 Feb 18;86(7):162-5
13311443
J Am Med Assoc. 1956 Dec 1;162(14):1303-4
13366746